The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Incidence and prevalence of hepatitis C in prisons and other closed settings: Results of a systematic review and meta-analysis
Open accessAbstract
People detained in prisons and other closed settings are at elevated risk of infection with hepatitis C virus (HCV). We undertook a systematic review and meta-analysis with the aim of determining the rate of incident HCV infection and the prevalence of anti-HCV among detainees in closed settings. We systematically searched databases of peer-reviewed literature and widely distributed a call for unpublished data. We calculated summary estimates of incidence and prevalence among general population detainees and detainees with a history of injection drug use (IDU), and explored heterogeneity through stratification and meta-regression. The summary prevalence estimates were used to estimate the number of anti-HCV positive prisoners globally. HCV incidence among general detainees was 1.4 per 100 person-years (py; 95% confidence interval [CI]: 0.1, 2.7; k = 4), and 16.4 per 100 py (95% CI: 0.8, 32.1; k = 3) among detainees with a history of IDU. The summary prevalence estimate of anti-HCV in general detainees was 26% (95% CI: 23%, 29%; k = 93), and in detainees with a history of IDU, 64% (95% CI: 58%, 70%; k = 51). The regions of highest prevalence were Central Asia (38%; 95% CI 32%, 43%; k = 1) and Australasia (35%; 95% CI: 28%, 43%; k = 9). We estimate that 2.2 million (range: 1.4-2.9 million) detainees globally are anti-HCV positive, with the largest populations in North America (668,500; range: 553,500-784,000) and East and Southeast Asia (638,000; range: 332,000-970,000). Conclusion : HCV is a significant concern in detained populations, with one in four detainees anti-HCV-positive. Epidemiological data on the extent of HCV infection in detained populations is lacking in many countries. Greater attention towards prevention, diagnosis, and treatment of HCV infection among detained populations is urgently required. (Hepatology 2013;58:1215–1224)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Mohd Hanafiah, K., Groeger, J., Flaxman, A. D., & Wiersma, S. T. (2013) · Hepatology · doi:10.1002/hep.26141 · Cited by 2,515
The global burden of hepatitis C
Lavanchy, D. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01934.x · Cited by 1,368
Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review
Mathers, B. M., Degenhardt, L., Phillips, B., Wiessing, L., Hickman, M., Strathdee, S. A., Wodak, A., Panda, S., Tyndall, M., Toufik, A., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61311-2 · Cited by 1,285
Self-citationNelson, P. K., Mathers, B. M., Cowie, B., Hagan, H., Des Jarlais, D., Horyniak, D., & Degenhardt, L. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61097-0 · Cited by 1,267
Self-citationGhany, M. G., Nelson, D. R., Strader, D. B., Thomas, D. L., & Seeff, L. B. (2011) · Hepatology · doi:10.1002/hep.24641 · Cited by 1,076
Metan: fixed- and random-effects meta-analysis
Harris, R. J., Deeks, J. J., Altman, D. G., Bradburn, M. J., Harbord, R. M., & Sterne, J. A. C. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800102 · Cited by 1,027
Harbord, R. M., & Higgins, J. P. T. (2008) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0800800403 · Cited by 897
Global Burden of Disease (GBD) for Hepatitis C
The Global Burden of Hepatitis C Working Group (2004) · The Journal of Clinical Pharmacology · doi:10.1177/0091270003258669 · Cited by 488
Hagan, H., Pouget, E. R., & Des Jarlais, D. C. (2011) · Journal of Infectious Diseases · doi:10.1093/infdis/jir196 · Cited by 313
Self-citationHIV in prison in low-income and middle-income countries
Dolan, K., Kite, B., Black, E., Aceijas, C., & Stimson, G. V. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70685-5 · Cited by 246
Hagan, H., Pouget, E. R., Des Jarlais, D. C., & Lelutiu-Weinberger, C. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn237 · Cited by 222
Self-citationInterventions to reduce HIV transmission related to injecting drug use in prison
Jürgens, R., Ball, A., & Verster, A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70305-0 · Cited by 202
HIV Coinfection With Hepatitis C Virus: Evolving Epidemiology and Treatment Paradigms
Taylor, L. E., Swan, T., & Mayer, K. H. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis367 · Cited by 156
Correlates of hepatitis C virus seropositivity in prison inmates: a meta-analysis
Vescio, M. F., Longo, B., Babudieri, S., Starnini, G., Carbonara, S., Rezza, G., & Monarca, R. (2008) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2006.051599 · Cited by 152
Treatment of Chronic Hepatitis C in a State Correctional Facility
Allen, S., Spaulding, A. C., Osei, A. M., Taylor, L. E., Cabral, A. M., & Rich, J. D. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00010 · Cited by 131
Self-citationLarney, S., Toson, B., Burns, L., & Dolan, K. A. (2011) · Addiction · doi:10.1111/j.1360-0443.2011.03618.x · Cited by 115
Self-citationGough, E. K., Kempf, M.-C., Graham, L. A., Manzanero, M., Hook, E. W., Bartolucci, A., & Chamot, E. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-777 · Cited by 112
WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs
Walsh, N. M., Verster, A. D., Rodolph, M., & Akl, E. A. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.01.009 · Cited by 85
Larney, S., & Dolan, K. A. (2009) · European Addiction Research · doi:10.1159/000199046 · Cited by 73
Self-citationHigh-risk drug-use practices among a large sample of Australian prisoners
Kinner, S. A., Jenkinson, R., Gouillou, M., & Milloy, M. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.05.008 · Cited by 69
Kheirandish, P., SeyedAlinaghi, S., Jahani, M., et al. (2009) · Journal of Urban Health · doi:10.1007/s11524-009-9393-0 · Cited by 64
Post, J. J., Lloyd, A. R., Dolan, K. A., et al. (2001) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2001.tb143214.x · Cited by 63
The harm inside: Injection during incarceration among male injection drug users in Tijuana, Mexico
Pollini, R. A., Alvelais, J., Gallardo, M., Vera, A., Lozada, R. M., Magis-Rodriquez, C., & Strathdee, S. A. (2009) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2009.03.005 · Cited by 50
Boonwaat, L., Haber, P., Levy, M. H., & Lloyd, A. R. (2010) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03605.x · Cited by 45
Hayashi, K., Milloy, M., Fairbairn, N. S., Kaplan, K., Suwannawong, P., Lai, C., Wood, E., & Kerr, T. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-492 · Cited by 42
Ogilvie, E. L., Veit, F. C. M., Crofts, N., & Thompson, S. (1999) · Journal of Adolescent Health · doi:10.1016/s1054-139x(98)00086-x · Cited by 38
Chu, F., Chiang, S.-C., Su, F., Chang, Y., & Cheng, S. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21481 · Cited by 34
Transmission of hepatitis C through tattooing in a United States prison
Tsang, T. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)02291-2 · Cited by 24
The HCV Synthesis Project: Scope, methodology, and preliminary results
Stern, R., Hagan, H., Lelutiu‐Weinberger, C., Jarlais, D. D., Scheinmann, R., Strauss, S. M., Pouget, E. R., & Flom, P. L. (2008) · BMC Medical Research Methodology · doi:10.1186/1471-2288-8-62 · Cited by 24
Self-citationDiagnosis and Treatment of Acute Hepatitis C Virus Infection
Boesecke, C., Wedemeyer, H. H., & Rockstroh, J. K. (2012) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2012.08.011 · Cited by 22
Cited by
Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., Stone, J., Cunningham, E. B., Trickey, A., Dumchev, K., et al. (2017) · The Lancet Global Health · doi:10.1016/s2214-109x(17)30375-3 · Cited by 1,429
Self-citationEASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Public health and international drug policy
Csete, J., Kamarulzaman, A., Kazatchkine, M., Altice, F., Balicki, M., Buxton, J., Cepeda, J., Comfort, M., Goosby, E., Goulão, J., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00619-x · Cited by 641
The Growth of Incarceration in the United States: Exploring Causes and Consequences
(2014) · National Academies Press eBooks · doi:10.17226/18613 · Cited by 599
Spearman, C. W., Dusheiko, G. M., Hellard, M., & Sonderup, M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32320-7 · Cited by 404
Metadata
- Authors
- Larney, S., Kopinski, H., Beckwith, C. G., Zaller, N. D., Jarlais, D. D., Hagan, H., Rich, J. D., van den Bergh, B. J., & Degenhardt, L.
- Venue
- Hepatology
- Published
- 2013-10
- Volume
- 58
- Issue
- 4
- Pages
- 1215-1224
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2143718001
- Cited by
- 314
- References
- 36
- FWCI
- 3.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.